A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

A decades-long study of Danish conscripts finds that despite the rise in obesity, the inverse relationship between intelligence and BMI has remained unchanged.

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

February is National Cancer Prevention Awareness Month, and you might be wondering if there are steps you can take to lower ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Discover how small biotechs are innovating in the weight loss therapy market with new treatments targeting unique mechanisms ...

High consumption of ultraprocessed foods containing high levels of added sugars, saturated fat, and sodium is associated with obesity in early childhood, especially in boys.

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...